<?xml version="1.0" encoding="UTF-8"?>
<p>Additionally, there is still ongoing work to develop a vaccine to prevent RSV infection. Recently, one study reported protective immunity against RSV with a molecularly adjuvanted adenovirus serotype 5 based RSV oral vaccine in a rat model (
 <xref rid="R69" ref-type="bibr">69</xref>). However, two recent randomized control failed to establish an effect of anti-RSV monoclonal antibodies and recurrent wheeze of early childhood or asthma (
 <xref rid="R70" ref-type="bibr">70</xref>â€“
 <xref rid="R73" ref-type="bibr">73</xref>).
</p>
